Digest Network Come funziona
Network
/
Società
Ab
Non verificato

AbbVie

Di cosa scriviamo

AgricolturaEcologia/Salute ambientaleFitnessMedicina - VarieSalute

10 comunicati stampa

Guarda tutti i comunicati
06/07/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
29/06/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
29/06/2026
Salute
Fitness
Medicina - Varie
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
29/06/2026
Salute
Fitness
Medicina - Varie
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
23/06/2026
Salute
Fitness
Medicina - Varie
Scienza
Ecologia/Salute ambientale
Agricoltura
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
22/06/2026
Salute
Fitness
Imprese
Industria
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
12/06/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
08/06/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
02/06/2026
Salute
Fitness
Medicina - Varie
AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults
Fonte
AbbVie
Emittente
PR News Wire
1.00
0
29/05/2026
Salute
Fitness
Amministrazione Pubblica
Medicina - Varie
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
Fonte
AbbVie
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0